Menu

Putting the Brakes on SARS-CoV-2: Neutralizing Antibodies

Experts will discuss potential neutralizing antibodies currently under investigation for SARS-CoV-2 treatment.

The Scientist Creative Services Team
Jul 6, 2020

FREE Webinar

Tuesday, July 28, 2020
2:30 - 4:00 PM, Eastern Standard Time

Register Now

SARS-CoV-2 is characterized by its rapid spread and significant human-to-human transmission. With no approved vaccines or treatments yet available, researchers are exploring various medical interventions, including neutralizing monoclonal antibodies (mAbs), to control the global COVID-19 pandemic. The SARS-CoV-2 spike (S) glycoprotein, which promotes entry into host cells, is the main target of neutralizing antibodies. In this multisponsored webinar by The Scientist, a panel of researchers will discuss potential neutralizing antibodies currently under investigation for SARS-CoV-2 treatment.

Topics to be covered

  • Human monoclonal antibodies for SARS-CoV-2
  • SARS-CoV-2 neutralizing antibodies for global access

Register Now

Meet the Speakers:

James E. Crowe, Jr., MD
Director, Vanderbilt Vaccine Center
Professor, Pediatrics and Pathology, Microbiology and Immunology
Ann Scott Carrell Chair

Devin Sok, PhD
Senior Director, Antibody Discovery and Development
IAVI


July/August 2020

Life During a Pandemic

Understanding the virus is just the beginning

Marketplace

Sponsored Product Updates

Horizon Discovery introduces single cell RNAseq-linked CRISPR screening service
CRISPR-based screening technology platform to address critical gaps in target ID and validationSingle cell RNAseq-linked pooled CRISPR screening offers high-quality screening data and biological insight
Coronavirus SeroAssay
Multiplexed coronavirus serological testing for examining vaccine efficacy
UV Disinfection in the Age of SARS-CoV-2
Download this white paper to learn about choosing the best wavelength for optimal disinfection and decontamination!
A Multi-omics Approach to Overcome Solid Tumor Drug Resistance
Download this research summary to learn about how single-cell proteomics and metabolomics methods unlock drug resistance mechanisms!